What are the latest funding news in the digital health market? (October 2026)
Everything we know about the digital health market, in one place. Get our report whether you build or invest.
Download our beautiful pitch about the digital health market
Digital health funding remained highly active entering October 2026, with capital flowing into clinical AI, patient access, virtual care, remote monitoring and health IT.
AI is now central to many of the newest digital health financings, particularly where software can automate clinical workflows, improve access to care or support healthcare professionals.
The latest deals also show a wide funding spectrum, from $3 million seed rounds to several transactions worth $100 million or more.
And if you want to better understand this new industry, you can download our pitch covering the digital health market.
Insights
- The 12 digital health deals in this sample were disclosed within roughly two weeks, showing how quickly capital is moving into healthcare AI, clinical workflow software and digitally enabled care.
- The companies represent about $900 million in announced financing when Heidi Health's full $340 million package is included, but roughly $660 million if its separate $240 million growth facility is excluded.
- The median financing is only about $10 million, despite several very large rounds, showing that the digital health funding market remains active across both early-stage and late-stage companies.
- Heidi Health, OpenEvidence and Angle Health account for close to 88% of the headline capital in this group, highlighting how strongly a few late-stage digital health companies can distort aggregate funding figures.
- Nine of the 12 companies use AI as a central product layer, particularly for clinical documentation, patient access, care navigation, monitoring, decision support and health coaching.
- Digital health investors are increasingly backing technologies that remove operational friction from healthcare, with patient scheduling, clinical documentation, care coordination and follow-up appearing repeatedly across the newest rounds.
- The United States features in the current market or expansion plans of 10 of the 12 companies, although the funding activity itself spans startups founded in the U.S., UK, Spain, Portugal, Australia and India.
- The funding mix remains broad, with seed, Series A, Series B and Series C transactions all represented, suggesting that digital health investment is not concentrated at a single company maturity stage.
- Tiny Health illustrates the expanding boundary of digital health, where diagnostics increasingly combine physical testing with personalized digital interpretation, practitioner tools and data-driven clinical insights.
Some business models leave very little on the table. Find out which ones in our digital health market report.
Summary table of the latest funding deals in the digital health market as of October 2026
We define the digital health market as products and services that use digital technology to deliver, support, or improve health care and health outcomes.
We include telehealth/virtual care, remote monitoring and connected devices, health IT and clinical workflow software, and patient-facing mobile apps when they are health-focused.
We exclude generic enterprise IT, purely consumer fitness/wellness products with no health use case, and biotech/lab R&D tools unless they directly power care delivery or clinical decision-making.
| Name | When | Amount in $ | Round Type | Category |
|---|---|---|---|---|
| Parakeet Health | October 1, 2026 | $10M | Series A | Patient access & health IT |
| Tiny Health | September 29, 2026 | $33M | Series B | Patient diagnostics & clinical intelligence |
| DYAD | September 29, 2026 | $10M | Series A | Health IT & clinical workflow |
| AngelEye Health | September 24, 2026 | $10M sold | Equity financing | Connected care & patient engagement |
| OpenEvidence | September 24, 2026 | $250M reported | Undisclosed | Clinical decision support |
| UltraSight | September 23, 2026 | $24M | Series B2 | Clinical AI & medical imaging |
| Usawa Care | September 23, 2026 | $3M | Seed | Virtual care & telehealth |
| Tucuvi | September 23, 2026 | About $5.7M | Growth investment | Remote monitoring & clinical AI |
| Heidi Health | September 22, 2026 | $340M package | Series C & growth facility | Clinical workflow & health IT AI |
| Disha | September 19, 2026 | About $5M | Series A | Patient app & chronic care |
| Angle Health | September 18, 2026 | $200M primary | Series C | Digital benefits & care navigation |
| Ferry Health | September 17, 2026 | $9M | Seed | Patient access & care navigation |
All the latest funding deals during in the digital health market as of October 2026
Parakeet Health raised $10 million in a Series A round in October 2026.
When was it?
Parakeet Health announced the Series A on October 1, 2026.
Who are they?
Parakeet Health provides conversational AI that handles healthcare front-office interactions across phone, SMS, email, web and fax.
Geographical focus?
Parakeet Health primarily serves U.S. healthcare providers and is expanding across a growing range of medical specialties.
Why do we include them in the digital health market?
Parakeet Health belongs to digital health because its patient-access and health IT platform connects patients with providers and automates healthcare-specific workflows.
What is the company stage?
Parakeet Health is at the PMF and early-growth stage, with rapid revenue growth and deployments across more than 1,100 locations.
How much did they raise?
Parakeet Health raised $10 million in new funding.
What round is it?
Parakeet Health's financing was a Series A led by Canvas Ventures.
Why did they raise?
Parakeet Health raised the capital to expand its technology, personalization capabilities, team and enterprise deployments across additional medical specialties.
Investors and the public don't always move at the same time. Our digital health market report shows who got there first.
Tiny Health raised $33 million in a Series B round in September 2026.
When was it?
Tiny Health announced the Series B on September 29, 2026.
Who are they?
Tiny Health provides at-home gut and vaginal microbiome testing with personalized digital results for consumers and healthcare practitioners.
Geographical focus?
Tiny Health is primarily U.S.-focused today, while its microbiome data and healthcare-partner platform can support broader international expansion.
Why do we include them in the digital health market?
Tiny Health fits the patient-facing diagnostics and clinical intelligence category because testing is combined with individualized digital health information and practitioner-facing tools.
What is the company stage?
Tiny Health is at the growth stage, with nearly 200,000 customers and more than 6,000 healthcare practitioners reported around the financing.
How much did they raise?
Tiny Health raised $33 million.
What round is it?
Tiny Health's financing was an oversubscribed Series B led by B Capital.
Why did they raise?
Tiny Health raised the capital for clinical research, practitioner education, expansion of its healthcare-partner platform and further development of its data and AI capabilities.
DYAD disclosed a $10 million Series A financing in September 2026.
When was it?
DYAD publicly announced the financing on September 29, 2026, although the Series A had closed earlier in April.
Who are they?
DYAD uses healthcare-specific AI to convert unstructured clinical documents into structured patient data, codes and workflow actions.
Geographical focus?
DYAD currently has a strong UK and NHS focus, with plans to expand into additional healthcare markets.
Why do we include them in the digital health market?
DYAD belongs to the health IT and clinical workflow category because its software directly structures healthcare information and integrates it into patient records and care workflows.
What is the company stage?
DYAD is at the PMF and early-growth stage, with its BetterLetter product already used across more than 200 GP practices.
How much did they raise?
DYAD raised $10 million, equivalent to approximately £7.5 million.
What round is it?
DYAD's financing was a Series A led by Sangha Capital.
Why did they raise?
DYAD raised the capital to expand across the NHS, move further into secondary care and enter additional geographic markets.
AngelEye Health disclosed almost $10 million of equity financing in September 2026.
When was it?
AngelEye Health's latest Form D financing disclosure was filed on September 24, 2026, following a first sale on September 10.
Who are they?
AngelEye Health provides neonatal and pediatric hospitals with bedside cameras, family communication, feeding management and digital patient education tools.
Geographical focus?
AngelEye Health primarily serves hospitals and neonatal care teams in the United States.
Why do we include them in the digital health market?
AngelEye Health belongs to connected care and patient engagement because its digital platform links hospitalized children, families and clinical teams.
What is the company stage?
AngelEye Health is a growth-stage company with an established hospital-focused platform and more than a decade of operating history.
How much did they raise?
AngelEye Health reported approximately $10 million sold to investors under the latest disclosed equity offering.
What round is it?
AngelEye Health disclosed an equity financing, while the formal round label was not confirmed in the filing.
Why did they raise?
AngelEye Health did not publicly disclose a specific use of proceeds for this financing.
We track how fast challengers are gaining on the incumbents. Our digital health market report covers every player worth watching.
OpenEvidence reportedly raised $250 million at a $15 billion valuation in September 2026.
When was it?
OpenEvidence's latest financing was reported on September 24, 2026.
Who are they?
OpenEvidence provides physicians with an AI clinical-information platform that synthesizes medical evidence to support diagnosis and treatment decisions.
Geographical focus?
OpenEvidence has particularly strong adoption among physicians in the United States.
Why do we include them in the digital health market?
OpenEvidence belongs to clinical decision support because physicians use the digital platform directly when answering medical questions and making care decisions.
What is the company stage?
OpenEvidence is at the hypergrowth and late-stage phase, with substantial adoption among U.S. clinicians.
How much did they raise?
OpenEvidence reportedly raised $250 million in the latest financing.
What round is it?
OpenEvidence's specific round label had not been publicly confirmed as of the October 2026 cutoff.
Why did they raise?
OpenEvidence is scaling its medical AI platform and the infrastructure required to support rapidly growing physician usage, although a detailed allocation was not disclosed.
UltraSight raised $24 million in a Series B2 round in September 2026.
When was it?
UltraSight announced the financing on September 23, 2026.
Who are they?
UltraSight develops AI software that guides healthcare professionals while acquiring cardiac ultrasound images.
Geographical focus?
UltraSight is currently concentrating commercial expansion on U.S. healthcare systems while building from its Israeli technology base.
Why do we include them in the digital health market?
UltraSight belongs to clinical AI and medical imaging because its software directly guides healthcare professionals during diagnostic cardiac imaging workflows.
What is the company stage?
UltraSight is at the commercial-growth stage, with regulatory clearances, clinical evidence and deployments in healthcare facilities.
How much did they raise?
UltraSight raised $24 million.
What round is it?
UltraSight's financing was a Series B2 led by Alive HealthTech Growth Fund.
Why did they raise?
UltraSight raised the capital to expand U.S. commercialization, develop additional cardiac workflows and build strategic cardiovascular partnerships.
Usawa Care raised $3 million in a seed round in September 2026.
When was it?
Usawa Care announced the seed financing on September 23, 2026.
Who are they?
Usawa Care combines AI with physician oversight to provide digital pediatric care, remote consultations and clinical support.
Geographical focus?
Usawa Care started in Portugal and is preparing to expand into the United States while extending its platform into adult care.
Why do we include them in the digital health market?
Usawa Care is a clear virtual-care and telehealth company because its technology directly connects patients with clinicians and supports healthcare delivery remotely.
What is the company stage?
Usawa Care is at the seed and early-PMF stage, with more than 10,000 children already served around the financing.
How much did they raise?
Usawa Care raised $3 million.
What round is it?
Usawa Care's financing was a seed round led by Armilar Venture Partners.
Why did they raise?
Usawa Care raised the capital to hire product and AI talent, launch adult healthcare services and support its U.S. expansion.
Disruption is real in this market. See which incumbents are struggling in our digital health market report.
Tucuvi secured a €5 million growth investment in September 2026.
When was it?
Tucuvi's new investment was announced on September 23, 2026.
Who are they?
Tucuvi provides a clinical voice AI agent that calls patients, follows care protocols, collects health information and sends structured data to care teams.
Geographical focus?
Tucuvi was founded in Spain and already works across Europe and the United States, with further international expansion planned.
Why do we include them in the digital health market?
Tucuvi belongs to remote patient monitoring and clinical AI because its regulated technology directly follows patients and connects their health information with care teams.
What is the company stage?
Tucuvi is at the growth stage, with established healthcare deployments and a regulated clinical product.
How much did they raise?
Tucuvi received €5 million, equivalent to roughly $5.7 million.
What round is it?
Tucuvi's financing is best described as a growth investment or Series A extension rather than a new standalone Series A.
Why did they raise?
Tucuvi raised the capital to enter new markets, develop additional healthcare AI products and strengthen partnerships with hospitals and health systems.
Heidi Health secured a $340 million financing package in September 2026.
When was it?
Heidi Health's financing was disclosed on September 22, 2026.
Who are they?
Heidi Health develops an AI care partner that creates clinical documentation and automates administrative workflows surrounding patient consultations.
Geographical focus?
Heidi Health operates globally, with strong adoption in Australia and Europe and a growing North American presence.
Why do we include them in the digital health market?
Heidi Health belongs to clinical workflow and health IT AI because its software is purpose-built to support clinicians and automate healthcare-specific work.
What is the company stage?
Heidi Health is at the hypergrowth stage, with millions of clinical consultations supported each week.
How much did they raise?
Heidi Health announced $340 million in financing, comprising $100 million of Series C equity and a separate $240 million growth investment facility.
What round is it?
Heidi Health's primary equity financing was a $100 million Series C, alongside the separate growth facility.
Why did they raise?
Heidi Health raised the financing to expand beyond documentation into broader clinical workflows and accelerate international commercialization.
Disha raised approximately $5 million in a Series A round in September 2026.
When was it?
Disha's Series A financing was disclosed in September 2026, with the deal dated September 19.
Who are they?
Disha, formerly Curelink, operates an AI health-coaching app for personalized diet, fitness and chronic-condition support.
Geographical focus?
Disha primarily focuses on consumers in India and supports users in English, Hindi and Hinglish.
Why do we include them in the digital health market?
Disha belongs to patient-facing digital health and chronic-care management because its app supports people managing specific health conditions rather than offering generic fitness content.
What is the company stage?
Disha is at the PMF and growth stage, with millions of sign-ups and hundreds of thousands of active users reported around the financing.
How much did they raise?
Disha raised ₹438.8 million, equivalent to roughly $5 million.
What round is it?
Disha's financing was a Series A led by General Catalyst.
Why did they raise?
Disha raised the capital to strengthen its AI models and technology, provide working capital and support broader business expansion.
Some established players have been hit hard by new competition. Our digital health market report shows who's losing ground and why.
Angle Health raised $200 million of primary capital in a September 2026 Series C.
When was it?
Angle Health announced the transaction on September 18, 2026.
Who are they?
Angle Health operates a technology-enabled employer health plan platform combining insurance administration, benefits navigation and access to healthcare.
Geographical focus?
Angle Health focuses on the United States and serves employers across most U.S. states.
Why do we include them in the digital health market?
Angle Health fits digital benefits and care navigation because its healthcare-focused technology helps employers and members manage health coverage and access care.
What is the company stage?
Angle Health is at the profitable growth stage, with thousands of employer customers and several consecutive profitable quarters reported around the financing.
How much did they raise?
Angle Health raised $200 million of new Series C capital as part of a $600 million transaction that also included a $400 million tender offer.
What round is it?
Angle Health's new primary financing was a Series C led by Vitruvian Partners.
Why did they raise?
Angle Health raised the capital to expand its technology infrastructure and commercial reach among small and midsize employers.
Ferry Health raised $9 million in seed funding in September 2026.
When was it?
Ferry Health's $9 million seed financing was publicly disclosed in September 2026.
Who are they?
Ferry Health provides an AI healthcare concierge that finds suitable in-network providers, calls clinics and books medical appointments for patients.
Geographical focus?
Ferry Health focuses on the United States, with institutional partnerships providing access to patients across all 50 states.
Why do we include them in the digital health market?
Ferry Health belongs to patient access and care navigation because its digital agent directly helps patients move from a healthcare need to a confirmed medical appointment.
What is the company stage?
Ferry Health is at the seed and early-PMF stage, with distribution relationships already giving more than one million people access to the service.
How much did they raise?
Ferry Health raised $9 million.
What round is it?
Ferry Health's financing was a seed round backed by Andreessen Horowitz, Index Ventures and several other investors.
Why did they raise?
Ferry Health raised the capital to scale its AI care-navigation platform and automate more of the administrative work patients face when accessing healthcare.
We check whether the money follows what's actually happening on the ground. See it in our digital health market report.
